Literature DB >> 30301561

Too many women are dying from cervix cancer: Problems and solutions.

David K Gaffney1, Mia Hashibe2, Deanna Kepka3, Kathryn A Maurer4, Theresa L Werner5.   

Abstract

One woman dies from cervix cancer every 2 min, adding up to over 270,000 deaths globally per year. This cancer affects a young population, and hence, the loss of life is staggering. There are many aspects of prevention, screening, and care that are suboptimal. A great deal is known about HPV induced carcinogenesis, yet clinical outcomes have been stagnant over decades. There has been no improvement in cervix cancer survival in the US since the mid-1970s [1]. With increased knowledge of the disease and greater worldwide resources including prevention, screening, and improved therapeutics, there is significant promise for fewer women to die from this virally induced cancer. We focus here on the major problems in prevention, screening, and delivery of care for cervix cancer and provide concrete solutions. With appropriate focus, a major improvement in survival from cervix cancer could be achieved in a short time span. Published by Elsevier Inc.

Entities:  

Keywords:  Cervix cancer; Chemotherapy; Disparities; Implementation; Radiation

Mesh:

Year:  2018        PMID: 30301561      PMCID: PMC6281756          DOI: 10.1016/j.ygyno.2018.10.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  74 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.

Authors:  Sang-Young Ryu; Won-Moo Lee; Kidong Kim; Sang-Il Park; Beob-Jong Kim; Moon-Hong Kim; Seok-Cheol Choi; Chul-Koo Cho; Byung-Ho Nam; Eui-Don Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-08-11       Impact factor: 7.038

3.  National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.

Authors:  Meg Watson; Vicki Benard; Jessica King; Anatasha Crawford; Mona Saraiya
Journal:  Prev Med       Date:  2017-05-11       Impact factor: 4.018

4.  Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study.

Authors:  Patricia J Eifel; Alex Ho; Najma Khalid; Beth Erickson; Jean Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

5.  Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.

Authors:  Kristine Bauer-Nilsen; Colin Hill; Daniel M Trifiletti; Bruce Libby; Donna H Lash; Melody Lain; Deborah Christodoulou; Constance Hodge; Timothy N Showalter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-14       Impact factor: 7.038

6.  The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer.

Authors:  J McLachlan; S Boussios; A Okines; D Glaessgen; S Bodlar; R Kalaitzaki; A Taylor; S Lalondrelle; M Gore; S Kaye; S Banerjee
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-11-09       Impact factor: 4.126

7.  Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.

Authors:  Anna L Beavis; Patti E Gravitt; Anne F Rositch
Journal:  Cancer       Date:  2017-01-23       Impact factor: 6.860

8.  Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.

Authors:  Laia Bruni; Mireia Diaz; Leslie Barrionuevo-Rosas; Rolando Herrero; Freddie Bray; F Xavier Bosch; Silvia de Sanjosé; Xavier Castellsagué
Journal:  Lancet Glob Health       Date:  2016-07       Impact factor: 26.763

Review 9.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

10.  Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.

Authors:  Meg Watson; Vicki Benard; Elaine W Flagg
Journal:  Prev Med Rep       Date:  2018-02-02
View more
  20 in total

1.  Development of a text message-based intervention for follow-up colposcopy among predominately underserved Black and Hispanic/Latinx women.

Authors:  Maria Sansoni; Erin K Tagai; Emmanuel Lapitan; Kuang-Yi Wen; Jenny Xu; Andrew Belfiglio; Shawna V Hudson; Racquel E Kohler; Enrique Hernandez; Suzanne M Miller
Journal:  Cancer Causes Control       Date:  2022-03-25       Impact factor: 2.532

Review 2.  Human Papilloma Virus-Associated Cervical Cancer and Health Disparities.

Authors:  Patti Olusola; Hirendra Nath Banerjee; Julie V Philley; Santanu Dasgupta
Journal:  Cells       Date:  2019-06-21       Impact factor: 6.600

3.  Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe.

Authors:  Mihai Stanca; Mihai Emil Căpîlna
Journal:  Diagnostics (Basel)       Date:  2021-03-22

4.  Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.

Authors:  Md Emtiaz Hasan; Maliha Matin; Md Enamul Haque; Md Abdul Aziz; Md Shalahuddin Millat; Mohammad Sarowar Uddin; Md Mizanur Rahman Moghal; Mohammad Safiqul Islam
Journal:  Cancer Med       Date:  2021-02-14       Impact factor: 4.452

5.  The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.

Authors:  Zhilin Song; Yanru Cui; Qiufu Li; Junhang Deng; Xianping Ding; Jiaoyu He; Yiran Liu; Zhuang Ju; Liyuan Fang
Journal:  Virol J       Date:  2021-05-03       Impact factor: 4.099

6.  Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019.

Authors:  Xingxing Zhang; Qingle Zeng; Wenwen Cai; Weiqing Ruan
Journal:  BMC Public Health       Date:  2021-05-12       Impact factor: 3.295

7.  Bibliometric analysis of global scientific literature on vaccine hesitancy in peer-reviewed journals (1990-2019).

Authors:  Waleed M Sweileh
Journal:  BMC Public Health       Date:  2020-08-17       Impact factor: 3.295

8.  Score for the Overall Survival Probability of Patients With First-Diagnosed Distantly Metastatic Cervical Cancer: A Novel Nomogram-Based Risk Assessment System.

Authors:  Shilong Zhang; Xin Wang; Zhanming Li; Wenrong Wang; Lishun Wang
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

9.  Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.

Authors:  Yunyan Chen; Mengfei Guo; Ding Qu; Yuping Liu; Jian Guo; Yan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

10.  Cervical Cancer Mortality in Romania: Trends, Regional and Rural-Urban Inequalities, and Policy Implications.

Authors:  Florentina Furtunescu; Roxana Elena Bohiltea; Adrian Neacsu; Corina Grigoriu; Corina Silvia Pop; Nicolae Bacalbasa; Ionita Ducu; Ana-Maria Iordache; Radu Virgil Costea
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.